Daily pill for ‘devastating and debilitating’ cancer to be rolled out on NHS

A DAILY pill for the most common form of bladder cancer has been given the green light for NHS use.

Erdafitinib, which blocks certain proteins to slow down or stop the growth of cancer cells, is expected to benefit hundreds of people.

BalversaErdafitinib, made by Johnson & Johnson, could benefit hundreds of people in England[/caption]

The drug, also known as Balversa and made by Johnson & Johnson, has been recommended by the National Institute of Health and Care...